TIRSKIA
Live / Applied — Second extension granted (statement of use) (as of 30 Oct 2025)
What this means for you
Not registered yet, but its 15 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98648551
- Mark type
- Stylized text
- Filed
- 15 Jul 2024
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Jelena Libby
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology and hematology
Owner
- Genentech, Inc., South San Francisco, CA, US
- Genentech, Inc., South San Francisco, CA, US
Prosecution history
- 30 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Oct 2025 — SOU EXTENSION 2 GRANTED
- 29 Oct 2025 — SOU EXTENSION 2 FILED
- 29 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jun 2025 — SOU EXTENSION 1 GRANTED
- 26 Jun 2025 — SOU EXTENSION 1 FILED
- 26 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2024 — PUBLISHED FOR OPPOSITION
- 20 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE